Nanoparticles as novel drug delivery systems for cancer treatment: current status and future perspectives

Cancer continues to pose a significant global health challenge, demanding innovative therapeutic approaches to overcome the limitations of conventional treatments like chemotherapy and radiotherapy. Nanoparticles (NPs) have emerged as promising tools for cancer therapy due to their unique physicoche...

Full description

Saved in:
Bibliographic Details
Main Authors: Liew, Kai Bin, Phang, Hiu Ching, Tan, Vinie Ying Xuan, Kee, Phei Er, Ming, Long Chiau, Vijayaraj Kumar, Palanirajan, Lee, Siew-Keah, Helal Uddin, A.B.M., Gilhotra, Ritu M., Ramanunny, Arya Kadukkattil
Format: Article
Language:en
en
en
Published: Bentham Science Publishers 2025
Subjects:
Online Access:http://irep.iium.edu.my/123745/1/123745_Nanoparticles%20as%20novel%20drug%20delivery.pdf
http://irep.iium.edu.my/123745/2/123745_Nanoparticles%20as%20novel%20drug%20delivery_SCOPUS.pdf
http://irep.iium.edu.my/123745/3/123745_Nanoparticles%20as%20novel%20drug%20delivery_WOS.pdf
http://irep.iium.edu.my/123745/
https://www.eurekaselect.com/article/147710
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1848450800971415552
author Liew, Kai Bin
Phang, Hiu Ching
Tan, Vinie Ying Xuan
Kee, Phei Er
Ming, Long Chiau
Vijayaraj Kumar, Palanirajan
Lee, Siew-Keah
Helal Uddin, A.B.M.
Gilhotra, Ritu M.
Ramanunny, Arya Kadukkattil
author_facet Liew, Kai Bin
Phang, Hiu Ching
Tan, Vinie Ying Xuan
Kee, Phei Er
Ming, Long Chiau
Vijayaraj Kumar, Palanirajan
Lee, Siew-Keah
Helal Uddin, A.B.M.
Gilhotra, Ritu M.
Ramanunny, Arya Kadukkattil
author_sort Liew, Kai Bin
building IIUM Library
collection Institutional Repository
content_provider International Islamic University Malaysia
content_source IIUM Repository (IREP)
continent Asia
country Malaysia
description Cancer continues to pose a significant global health challenge, demanding innovative therapeutic approaches to overcome the limitations of conventional treatments like chemotherapy and radiotherapy. Nanoparticles (NPs) have emerged as promising tools for cancer therapy due to their unique physicochemical properties that enable targeted drug delivery, reduced systemic toxicity, and enhanced therapeutic efficacy. This comprehensive review delves into the mechanisms of NP-based drug delivery, highlighting both passive and active targeting strategies. It categorizes and discusses diverse NP types, including polymeric, lipid-based, and metallic nanoparticles, emphasizing their applications in enhancing the bioavailability and specificity of anticancer agents. This review also explores the integration of advanced technologies, such as theranostics and artificial intelligence, to optimize NP design and functionality for personalized medicine. However, challenges remain, including issues related to toxicity, drug resistance, and manufacturing scalability. Addressing these barriers re- quires interdisciplinary research focused on developing stimuli-responsive NPs, improving biocompatibility, and incorporating multimodal therapeutic platforms. Although substantial progress has been made, this review is limited by the paucity of clinical trials validating NP efficacy and safety in diverse patient populations. Fu- ture endeavors should prioritize translational research to bridge the gap between preclinical innovations and clinical applications, ensuring that these transformative technologies benefit a broader spectrum of cancer pa- tients. The review underscores the immense potential of NPs in redefining cancer treatment while advocating for sustained research to address existing limitations and unlock their full therapeutic promise.
format Article
id my.iium.irep-123745
institution Universiti Islam Antarabangsa Malaysia
language en
en
en
publishDate 2025
publisher Bentham Science Publishers
record_format dspace
spelling my.iium.irep-1237452025-11-04T03:21:02Z http://irep.iium.edu.my/123745/ Nanoparticles as novel drug delivery systems for cancer treatment: current status and future perspectives Liew, Kai Bin Phang, Hiu Ching Tan, Vinie Ying Xuan Kee, Phei Er Ming, Long Chiau Vijayaraj Kumar, Palanirajan Lee, Siew-Keah Helal Uddin, A.B.M. Gilhotra, Ritu M. Ramanunny, Arya Kadukkattil QD Chemistry RM Therapeutics. Pharmacology RS192 Materia Medica-Pharmaceutical Technology RS403 Materia Medica-Pharmaceutical Chemistry Cancer continues to pose a significant global health challenge, demanding innovative therapeutic approaches to overcome the limitations of conventional treatments like chemotherapy and radiotherapy. Nanoparticles (NPs) have emerged as promising tools for cancer therapy due to their unique physicochemical properties that enable targeted drug delivery, reduced systemic toxicity, and enhanced therapeutic efficacy. This comprehensive review delves into the mechanisms of NP-based drug delivery, highlighting both passive and active targeting strategies. It categorizes and discusses diverse NP types, including polymeric, lipid-based, and metallic nanoparticles, emphasizing their applications in enhancing the bioavailability and specificity of anticancer agents. This review also explores the integration of advanced technologies, such as theranostics and artificial intelligence, to optimize NP design and functionality for personalized medicine. However, challenges remain, including issues related to toxicity, drug resistance, and manufacturing scalability. Addressing these barriers re- quires interdisciplinary research focused on developing stimuli-responsive NPs, improving biocompatibility, and incorporating multimodal therapeutic platforms. Although substantial progress has been made, this review is limited by the paucity of clinical trials validating NP efficacy and safety in diverse patient populations. Fu- ture endeavors should prioritize translational research to bridge the gap between preclinical innovations and clinical applications, ensuring that these transformative technologies benefit a broader spectrum of cancer pa- tients. The review underscores the immense potential of NPs in redefining cancer treatment while advocating for sustained research to address existing limitations and unlock their full therapeutic promise. Bentham Science Publishers 2025-04-16 Article PeerReviewed application/pdf en http://irep.iium.edu.my/123745/1/123745_Nanoparticles%20as%20novel%20drug%20delivery.pdf application/pdf en http://irep.iium.edu.my/123745/2/123745_Nanoparticles%20as%20novel%20drug%20delivery_SCOPUS.pdf application/pdf en http://irep.iium.edu.my/123745/3/123745_Nanoparticles%20as%20novel%20drug%20delivery_WOS.pdf Liew, Kai Bin and Phang, Hiu Ching and Tan, Vinie Ying Xuan and Kee, Phei Er and Ming, Long Chiau and Vijayaraj Kumar, Palanirajan and Lee, Siew-Keah and Helal Uddin, A.B.M. and Gilhotra, Ritu M. and Ramanunny, Arya Kadukkattil (2025) Nanoparticles as novel drug delivery systems for cancer treatment: current status and future perspectives. Current Pharmaceutical Design, 31 (39). pp. 3117-3127. ISSN 1381-6128 E-ISSN 1873-4286 https://www.eurekaselect.com/article/147710 10.2174/0113816128368718250320060346
spellingShingle QD Chemistry
RM Therapeutics. Pharmacology
RS192 Materia Medica-Pharmaceutical Technology
RS403 Materia Medica-Pharmaceutical Chemistry
Liew, Kai Bin
Phang, Hiu Ching
Tan, Vinie Ying Xuan
Kee, Phei Er
Ming, Long Chiau
Vijayaraj Kumar, Palanirajan
Lee, Siew-Keah
Helal Uddin, A.B.M.
Gilhotra, Ritu M.
Ramanunny, Arya Kadukkattil
Nanoparticles as novel drug delivery systems for cancer treatment: current status and future perspectives
title Nanoparticles as novel drug delivery systems for cancer treatment: current status and future perspectives
title_full Nanoparticles as novel drug delivery systems for cancer treatment: current status and future perspectives
title_fullStr Nanoparticles as novel drug delivery systems for cancer treatment: current status and future perspectives
title_full_unstemmed Nanoparticles as novel drug delivery systems for cancer treatment: current status and future perspectives
title_short Nanoparticles as novel drug delivery systems for cancer treatment: current status and future perspectives
title_sort nanoparticles as novel drug delivery systems for cancer treatment: current status and future perspectives
topic QD Chemistry
RM Therapeutics. Pharmacology
RS192 Materia Medica-Pharmaceutical Technology
RS403 Materia Medica-Pharmaceutical Chemistry
url http://irep.iium.edu.my/123745/1/123745_Nanoparticles%20as%20novel%20drug%20delivery.pdf
http://irep.iium.edu.my/123745/2/123745_Nanoparticles%20as%20novel%20drug%20delivery_SCOPUS.pdf
http://irep.iium.edu.my/123745/3/123745_Nanoparticles%20as%20novel%20drug%20delivery_WOS.pdf
http://irep.iium.edu.my/123745/
https://www.eurekaselect.com/article/147710
url_provider http://irep.iium.edu.my/